Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma

Allergology International

Volumn 61, Issue 3, 2012, Pages 411-417

  Kamimura, Mitsuhiro ^a   Izumi, Shinyu ^b   Hamamoto, Yoichiro ^a   Morita, Akane ^a   Toyota, Emiko ^b   Kobayashi, Nobuyuki ^b   Kudo, Koichiro ^b  

^a NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Budesonide; Cough; Dexamethasone; Nebulizer; Trachea

Indexed keywords

BUDESONIDE; DEXAMETHASONE SODIUM PHOSPHATE; FLUTICASONE PROPIONATE; FLUTIDE DISKUS; HISTAMINE H2 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGH PREDOMINANT ASTHMA; COUGH VARIANT ASTHMA; COUGHING; DISEASE EXACERBATION; DRUG DISTRIBUTION; DRUG MEGADOSE; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEMALE; HEARTBURN; HOARSENESS; HUMAN; MALE; MEDICAL NEBULIZER; METERED DOSE INHALER; POWDER INHALER; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; COUGH; DRY POWDER INHALERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867765367     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-OA-0357     Document Type: Article

References (36)

1. Boe J, Dennis JH, O'Driscoll BR et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001;18:228-242.
2. Hiller FC, Mazumder MK, Wilson JD, McLeod PC, Bone RC. Human respiratory tract deposition using multimodel aerosols. J Aerosol Sci 1982;33:337-343.
3. Martonen TB. Measurement of particle dose distribution in a model of a human larynx and tracheobronchial tree. J Aerosol Sci 1983;14:11-22.
4. Chan TL, Schreck RM. Effect of the laryngeal jet on particle deposition in the human trachea and upper bronchial airways. J Aerosol Sci 1980;11:447.
5. Schlesinger RB, Bohning DE, Chan TL. Particle deposition in a hollow cast of the human tracheobronchial tree. J Aerosol Sci 1977;8:429.
6. Corcoran TE, Chigier N. Inertial deposition effects: a study of aerosol mechanics in the trachea using laser Doppler velocimetry and fluorescent dye. J Biomech Eng 2002;124:629-637.
7. Lin CL, Tawhai MH, McLennan G, Hoffman EA. Characteristics of the turbulent laryngeal jet and its effect on air flow in the human intra-thoracic airways. Respir Physiol Neurobiol 2007;157:295-309.
8. Widdicombe J. Airway receptors. Respir Physiol 2001; 125:3-15.
9. Mazzone SB, Canning BJ. Plasticity of the cough reflex. Eur Respir Rev 2002;12:236-242.
10. Kamimura M, Mouri A, Takayama K et al. Cough challenge tests involving mechanical stimulation of the cervical trachea in patients with cough as a leading symptom. Respirology 2010;15:1244-1251.
11. Committee for the Japanese Respiratory Society Guidelines for Management of Cough, Kohno S, Ishida T et al. The Japanese Respiratory Society guidelines for management of cough. Respirology 2006;11 (Suppl 4):S135-S386.
12. Lallo UG, Barnes PJ, Chung KF. Pathophysiology and clinical presentations of cough. J Allergy Clin Immunol 1996;98:S91-S97.
13. Waldrep JC, Berlinski A, Dhand R. Comperative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer. J Aerosl Med 2007;20:310-319.
14. Berger WE, Shapiro GG. The use of inhaled corticosteroids for persistent asthma in infants and young children. Ann Allergy Asthma Immunol 2004;92:387-400.
15. Hoffmann NB, Laucka PV. Dexamethasone aerosol use in an asthmatic nursing-home patient with Parkinson's disease and dementia. Ann Pharmacother 1990;24:707-708.
16. Connolly KC, Peake MD, Halpin DMG, Golightly L, Turbitt ML; Astra Pharmaceuticals Research Group. Challenging current asthma treatment guidelines. Improved control of asthma symptoms with nebulised budesonide in patients with severe asthma receiving continuous oral steroids. Dis Manag Health Outcomes 2000;7:217-225.
17. Otulana BA, Varma N, Bullock A, Higenbottam T. High dose nebulized steroid in the treatment of chronic steroiddependent asthma. Respir Med 1992;86:105-108.
18. Westbroek J, Saarelainen S, Laher M, O'Brien J, Barnacle H, Efthimiou J. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respir Med 1999;93:689-699.
19. Higenbottam TW, Britton J, Lawrence D et al, And Pulmicort Respules versus Oral Steroids: A Prospective Clinical Trial in Acute Asthma (PROSPECTS): ADULT study team. Comparison of nebulised budesonide and prednisolone in severe asthma exacerbation in adults. BioDrugs 2000;14:247-254.
20. Mitchell CA, Alpers JH, Morton SM et al. Comparison of nebulized budesonide with oral prednisolone in the treatment of severe acute asthma. Eur Respir J 1995;8 (Suppl 19):490s.
21. Birk-Madsen E, Bundgaard A, Hidinger K-G. Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pear-shaped spacer and terbutaline in a nebulized solution. Eur J Clin Pharmacol 1982; 23:27-30.
22. Pedersen JZ, Bundgaard A. Comparative efficacy of different methods of nebulising terbutaline. Eur J Clin Pharmacol 1983;25:739-742.
23. Weber RW, Petty WE, Nelson HS. Aerosolized terbutaline in asthmatics. Comparison of dosage strength, schedule and method of administration. J Allergy Clin Immunol 1979;63:116-121.
24. Dahlström K, Thorsson L, Larsson P, Nikander K. Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol 2003;90:226-232.
25. Thorsson L, Edsbäcker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler (pMDI). Eur Respir J 1994;7:1839-1844.
26. Stoeck M, Riedel R, Hochhaus G et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004;309:249-258.
27. Farkas A, Balásházy I, Szocs K. Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods. J Aerosol Med 2006;19:329-343.
28. Balásházy I, Hofmann W. Deposition of aerosols in asymmetric airway bifurcations. J Aerosol Sci 1995;26:273-292.
29. Farkas A, Balásházy I. Quantification of particle deposition in asymmetrical tracheobronchial model geometry. Comput Biol Med 2008;38:508-518.
30. Check WA, Kaliner MA. Pharmacology and pharmacokinetics of topical corticosteroid derivatives used for asthma therapy. Am Rev Respir Dis 1990;141:S44-S451.
31. Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J Asthma 1994;31:463-472.
32. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11:1064-1069.
33. Niimi A, Matsumoto H, Minakuchi M, Kitaichi M, Amitani R. Airway remodelling in cough-variant asthma. Lancet 2000;356:564-565.
34. O'Connell EJ, Rojas AR, Sachs MI. Cough-type asthma: a review. Ann Allergy 1991;66:278-285.
35. Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 1999;104:S200-S209.
36. Szefler SJ, Lyzell E, Fitzpatrick S, Cruz-Rivera M. Safety profile of budesonide inhalation suspension in the pediatric population: Worldwide experience. Ann Allergy Asthma Immunol 2004;93:83-90.